News
Bankruptcy threat looms as Quince runs out of options
Investor panic has poleaxed Quince Therapeutics share price, after a regulatory filing revealed the biotech's cash is running out.
News
Lundbeck preps phase 3 for migraine prevention drug
Lundbeck seems to have brought its migraine prevention drug bocunebart back on track with positive data for an intravenous formulation.
News
ILiAD bags $115m for pertussis vaccine, and other financings
This week's biofinancings include a nine-figure round for ILiAD, with Quantx Bio, Aerska, Galux, and Pandorum Technologies also raising new funds.
News
BridgeBio gains on phase 3 dwarfism data
Shares in BridgeBio rose after it revealed data from a trial of infigratinib in achondroplasia, raising the prospect of the first oral treatment.
News
Euro VCs team up to invigorate life sciences ecosystem
Major venture capital groups in Europe have joined forces to set up a new coalition aimed at revitalising access to life sciences investment.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
